Functional reversal of (−)‐Stepholidine analogues by replacement of benzazepine substructure using the ring‐expansion strategy. (24th June 2016)
- Record Type:
- Journal Article
- Title:
- Functional reversal of (−)‐Stepholidine analogues by replacement of benzazepine substructure using the ring‐expansion strategy. (24th June 2016)
- Main Title:
- Functional reversal of (−)‐Stepholidine analogues by replacement of benzazepine substructure using the ring‐expansion strategy
- Authors:
- Li, Wei
Zhang, Li
Xu, Lili
Yuan, Congmin
Du, Peng
Chen, Jiaojiao
Zhen, Xuechu
Fu, Wei - Abstract:
- Abstract : (−)‐Stepholidine is an active ingredient of the Chinese herb Stephania and naturally occurring tetrahydroprotoberberine alkaloid with mixed dopamine receptor D1 agonistic and dopamine receptor D2 antagonistic activities. In this work, a series of novel hexahydrobenzo[4, 5]azepino [2, 1‐a]isoquinolines were designed and synthesized as ring‐expanded analogues of (−)‐Stepholidine. Initial pharmacological assays demonstrated that a benzazepine replacement was associated with significant increase in selectivity and functional reversal at dopamine receptor D1 . Compound‐(−)‐15e ( K i = 5.32 ± 0.01 nm ) is more potent than (−)‐Stepholidine ( K i = 13 nm ) and was identified as a selective dopamine receptor D1 antagonist (IC50 = 0.14 μ m ). Moreover, molecular modeling suggested that (−)‐15e might exert its dopamine receptor D1 antagonistic activities through interacting with the transmembrane helix 7 of dopamine receptor D1 . Abstract : A series of novel ring‐expanded analogues of (−)‐Stepholidine ( l ‐SPD) were designed, synthesized and bioassayed as potent ligands at D1R. Compound‐(− )‐15e ( K i = 5.32 ± 0.01 nm ) is more potent than l ‐SPD ( K i = 13 nm ) and was identified as a selective D1R antagonist (IC50 = 0.14 μ m ). This structural modification was associated with significant increase in selectivity and functional reversal at D1R in comparison with (−)‐ l ‐SPD with dual D1R agonistic and D2R antagonistic activities.
- Is Part Of:
- Chemical biology & drug design. Volume 88:Number 4(2016)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 88:Number 4(2016)
- Issue Display:
- Volume 88, Issue 4 (2016)
- Year:
- 2016
- Volume:
- 88
- Issue:
- 4
- Issue Sort Value:
- 2016-0088-0004-0000
- Page Start:
- 599
- Page End:
- 607
- Publication Date:
- 2016-06-24
- Subjects:
- dopamine D1 receptor -- Receptor and ligands (agonist/antagonist) -- selective D1R antagonists
Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.12796 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 448.xml